Search by Drug Name or NDC
NDC 00781-2865-05 Ranitidine Hydrochloride 300 mg/1 Details
Ranitidine Hydrochloride 300 mg/1
Ranitidine Hydrochloride is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sandoz Inc. The primary component is RANITIDINE HYDROCHLORIDE.
Product Information
| NDC | 00781-2865 |
|---|---|
| Product ID | 0781-2865_ed4bcd49-22fa-4c8d-834a-4b6085889b4b |
| Associated GPIs | 49200020100110 |
| GCN Sequence Number | 016224 |
| GCN Sequence Number Description | ranitidine HCl CAPSULE 300 MG ORAL |
| HIC3 | Z2D |
| HIC3 Description | HISTAMINE H2-RECEPTOR INHIBITORS |
| GCN | 19552 |
| HICL Sequence Number | 004520 |
| HICL Sequence Number Description | RANITIDINE HCL |
| Brand/Generic | Generic |
| Proprietary Name | Ranitidine Hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Ranitidine Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 300 |
| Active Ingredient Units | mg/1 |
| Substance Name | RANITIDINE HYDROCHLORIDE |
| Labeler Name | Sandoz Inc |
| Pharmaceutical Class | Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA074655 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00781-2865-05 (00781286505)
| NDC Package Code | 0781-2865-05 |
|---|---|
| Billing NDC | 00781286505 |
| Package | 500 CAPSULE in 1 BOTTLE (0781-2865-05) |
| Marketing Start Date | 1997-10-22 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |